EICHORPublic-registry site landscape for NCT02372240, “A Study of VLX1570 and Dexamethasone in Myeloma Patients”, a Multiple Myeloma study sponsored by Vivolux AB. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT02372240 (registry record) |
| Study title | A Study of VLX1570 and Dexamethasone in Myeloma Patients |
| Official title | VLX1570 and Low-Dose Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma: A Clinical and Correlative Phase 1/2 Study |
| Sponsor | Vivolux AB |
| Condition(s) | Multiple Myeloma |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 1 |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT02372240.
Eichor generates a preliminary site-risk snapshot for NCT02372240 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Multiple Myeloma trials
← Eichor home · All tracked trials · Multiple Myeloma studies · Weekly briefs
